Wilmington, NC, February 14, 2019

TREADWELL Secures Grants from National Institute on Aging and North Carolina Department of Commerce

Treadwell’s Impact on Peripheral Artery Disease to be studied by UNC Chapel Hill.

Treadwell Corporation, with offices in Durham, NC and Ellsworth, ME, has received two grants to study the efficacy of their treadling system as impacts Peripheral Artery Disease. The grant from the National Institute on Aging, which is a division of the U.S. Department of Health and Human Services, was matched by the North Carolina Department of Commerce. The studies will be completed at the University of North Carolina at Chapel Hill by the Applied Biomechanics Laboratory, a joint venture with North Carolina State University.

“The Treadwell Methodology™ is designed to improve blood flow velocity with no effect on pulse, blood pressure or respiration rate and has been proven to help with a number of medical diagnoses and conditions,” said Richard Hand, PT, creator and co-founder of Treadwell. “We’re thrilled to have a formal study undertaken here in our home state of North Carolina and hope it leads to a self-administered program for those suffering from peripheral artery disease.”

Patients of the Treadwell Methodology™ utilize a treadling machine combined with applications and strategies developed for specific disorders. Positive health claims as a result of using the Treadwell Methodology™ range from Restless Leg Syndrome and plantar fasciitis relief to Peripheral Artery Disease and other diagnoses and conditions.

“Many people with arterial diseases have a hard time walking, yet that’s the prescription they’re given The Treadwell Methodology™ provides a similar benefit as walking while the user is sitting” said Gerald Collins, CEO and Co-Founder of Treadwell Corporation. “Because the Treadwell Methodology™ increases the velocity of blood flow while the user is sitting, healing is accelerated with fatigue. We believe it is the solution to Sedentary Death Syndrome.”

The study, under the auspices of Dr. Jason Franz, PhD., is expected to be complete by September 2019.


Headquartered in Wilmington, NC, Treadwell Corporation was founded in 2005, and received a patent for the Treadwell Methodology™ in February 2011, which increases blood flow velocity using proprietary technology. The Treadwell Methodology™ combines near-effortless methodology and an ergonomically correct device designed with therapeutic best practices for accelerating blood flow velocity. Treadwell opened its second office in Ellsworth, ME in 2018. For more information, visit www.treadwellness.com

Treadwell Corporation

Members of :

First Flight Venture Center

RTP, NC 27709

Union River Center for Innovation

Ellsworth, ME 04605


  • facebook
  • Twitter Clean
  • w-googleplus

© 2018 by

Treadwell Corporation